REGISTERED
on 26 Mar 2024
Last Applicant/ Owned by
3-5-1, Nihonbashi Honcho
Chuo-ku, Tokyo
JP
103-8426
Serial Number
97797523 filed on 16th Feb 2023
Registration Number
7336285 registered on 26th Mar 2024
Correspondent Address
Bassam N. Ibrahim
Filing Basis
No Filing Basis
Disclaimer
NO DATA
CEMRIAV
Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressiva, systemic lupus erythematosus, Netherton syndrome; vaccines
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressiva, systemic lupus erythematosus, Netherton syndrome; vaccines
Mark Details
Serial Number
No 97797523
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 0076404-243
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Mar 2024 | REGISTERED-PRINCIPAL REGISTER |
| 26th Mar 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 09th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 30th Nov 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 30th Nov 2023 | EXAMINERS AMENDMENT E-MAILED |
| 30th Nov 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 30th Nov 2023 | EXAMINER'S AMENDMENT ENTERED |
| 30th Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |